THE COMPARATIVE ANALYSIS OF THE DRUG RESISTANCE OF MBTIN CHILDREN, ADOLESCENTS AND THE SOURCES OF INFECTION IN THE MULTIDRUG-RESISTANT TUBERCULOSIS FOCIES

Authors

  • Olha Ivanivna SAKHELASHVILI-BIL Department of Phthisiology and Pulmonology of Danylo Halytsky Lviv National Medical University. Ukraine
  • Manana Ivanivna SAKHELASHVILI Department of Phthisiology and Pulmonology of Danylo Halytsky Lviv National Medical University. Ukraine

DOI:

https://doi.org/10.52692/1857-0011.2021.3-71.18

Keywords:

MRTB, children, adolescents

Abstract

145 patients (67 children and 78 adolescents) from the multidrug-resistant tuberculosis infection focies took partin the complex microbiological study. The children and adolescents had undergone treatment for the pulmonary multidrug-resistant tuberculosis. The study showed that MDR TB was by 1.7 times more often revealed in the adolescents ascompared to the children, while the risk of MDR TB was by 3.7 times higher for the children than for the adolescents.The drug resistance profile of the children and the sources of infection almost completely coincided. The resistance toHRSE (66.1%) and HRESZ (13.6%) developed in the adolescents more often than in the children and adults. The studyproves the importance of defining the drug resistance profile in the exposed children and adolescents from the multidrug-resistant tuberculosis focies.

Author Biographies

Olha Ivanivna SAKHELASHVILI-BIL, Department of Phthisiology and Pulmonology of Danylo Halytsky Lviv National Medical University. Ukraine

postgraduate student.

Manana Ivanivna SAKHELASHVILI, Department of Phthisiology and Pulmonology of Danylo Halytsky Lviv National Medical University. Ukraine

holder of the habilitated doctor’s degree in Medical Science, Professor.

References

V.A. Aksionova, N.I. Klevno, S.M. Kavtarashvili and others. Tuberculosis infection site as the risk of multidrug-resistant tuberculosis for children. Tuberculosis and Lung Diseases, 2018; Vol.96.(1):11-1.DOI: https://DOI.org/10.21292/2075-1230-2018-96(1):11-7.

O.I. Bilohortseva, L.A. Sukhanova, I.Y. Shekhter and others. Multidrug-resistant tuberculosis in Ukraine versus the general tuberculosis incidence./Ukrainian Pulmonology Journal, 2019, 1. Enclosure: 15-20.

M.I. Sakhelashvili, I.L. Platonova, T.M. Balyta and others. Tuberculosis occurrence and tuberculosis profile among children and adolescents from the tuberculosis infection focies. Tuberculosis, pulmonary diseases, HIV-infection. 2012;2(9): 99-95.

Y.I. Feshechenko, V.M. Melnyk, M. Humeniuk, M.I. Lynnyk The Epidemiological situation of tuberculosis in Ukraine. Infusion & Chemotherapy,2019;4:5-9. DOI: https://doi.org/10.32902/2663-0338-2019-4-5-9.

Becerra, Mercedes C. ScD, et al. Tuberculosis in Children Exposed at Home to Multidrug-resistant Tuberculosis The Pediatric Infectious Disease Journal: February 2013; Vol.32,Issue 2:115-119. DOI: 10.1097/INF.0b013e31826f6063.

Bielecka T. et al. Recommendations for the management of tuberculosis in children — kompass TB. Part 1: Tuberculosis prevention. Adv Respir Med. 2018; 149-7.

James A Seddon et al. Multidrug-resistant tuberculosis in children and adolescents: current strategies for prevention and treatment. Expert Review of Respiratory Medicine. 2020; 221-237., Published online: 10 Oct 2020.

H. Simon Schaaf, and Ben J. Marais. The Role of Xpert MTB/RIF Ultra in Diagnosing Pulmonary Tuberculosis in Children. American J. of Respiratory and Critical Care Medicine. PubMed: 31386819.

Downloads

Published

2021-11-17

Issue

Vol. 71 No. 3 (2021): Medical Sciences

Section

Research Article

License

Copyright (c) 2022 Bulletin of the Academy of Sciences of Moldova. Medical Sciences

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.